J.H. OORTWEG 21, LEIDEN, P7
Annual Report for the Fiscal Year Ended December 31, 2025
Unaudited Condensed Consolidated Interim Financial Statements For the Three Months Ended March 31, 2026
Enters Into Underwriting Agreement with Morgan Stanley & Co. LLC and Leerink Partners LLC
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Pioneering Science for Patient Choice Presentation January 2026
Announces Positive Topline Data from RAPIDe-3 Pivotal Study Confirming Potential of Deucrictibant for On-Demand Treatment of HAE Attacks
Unaudited Condensed Consolidated Interim Financial Statements For the Nine Months Ended September 30, 2025
Registration Rights Agreement
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
No filings found
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Amended Statement of Changes in Beneficial Ownership
Automatic Shelf Registration Statement
Submission Upload
Correspondence
Free Writing Prospectus
Automatic Shelf Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Amended Notice of Proposed Sale of Securities